The U.S. Office of Naval Research (ONR) awarded a $247,955.00 firm fixed-price purchase order to DNA Script Inc., a foreign-owned, for-profit company based in Daly City, California. The contract is for the procurement of a Syntax Model STX-200 DNA synthesizer system, associated on-premises console software, and a laptop bundle. This sole-source procurement was conducted under Simplified Acquisition Procedures and did not have a set-aside designation. The contract supports critical research...
The U.S. Army Medical Research Acquisition Activity (USAMRAA) awarded a sole source, firm fixed price contract worth $404,505.00 to DNA Script Inc., a foreign-owned, for-profit business, to provide a benchtop DNA synthesizer and four-year maintenance plan. The synthesizer will support targeted pathogen discovery efforts at the United States Army Medical Research Institute of Infectious Diseases (USAMRIID). DNA Script Inc. is the sole source provider of this specialized equipment, which can...
The U.S. Department of Health and Human Services' National Institute of Allergy and Infectious Diseases (NIAID) awarded a $70,000.00 Firm Fixed Price Purchase Order to Bioautomation Corporation for the delivery of a DNA Synthesizer/Bioauto system. The contract has a completion date of September 22, 2014 and was awarded on August 21, 2014. This award does not utilize a set-aside designation. As the NIAID is focused on biomedical and infectious disease research, this DNA synthesis equipment is...
The United States Department of Agriculture Animal and Plant Health Inspection Service Veterinary Services (USDA-APHIS) awarded a $314,160 firm fixed price purchase order contract to DNA Script Inc. as the prime contractor to acquire an oligo synthesizer to generate primers for real-time and conventional polymerase chain reaction assays in-house at the National Center for Animal Health. The oligo synthesizer manufactured by DNA Script, the Syntax machine, utilizes a unique enzyme-based...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bio-Synthesis, Inc. (doing business as Dnaexam) for the custom synthesis of oligonucleotides. The contract has a ceiling value of $29,580.00 and an ultimate completion date of February 28, 2010. The agency indicates a high demand and usage level for these oligonucleotides, particularly for a recombinant vaccine project against...
This is a firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Genscript USA Inc. for $249,943.63 to provide DNA synthesis, plasmid, and protein production services. The contract supports ongoing research projects at the NIAID Vaccine Research Center and was awarded on a sole-source basis as Genscript was determined to be the only source capable of meeting the salient requirements. The award does not...
This federal contract award to Genscript USA Inc. is for $182,897.61 to provide custom gene synthesis services to the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH) within the Department of Health and Human Services. The contract is a firm fixed-price purchase order with no set-aside designation, and the services include DNA synthesis, subcloning, and plasmid preparation to support HIV research being conducted at the NIH...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $34,697.53 firm fixed price purchase order to Genscript USA Inc. to provide DNA services in support of vaccine development efforts. Under the contract, Genscript will deliver gene synthesis, VectorArk cloning, and express plasmid preparation services. These services will enable the creation of peptide and protein immunogens as well as DNA constructs containing...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $32,540.94 firm fixed price purchase order contract to Genscript USA Inc., a for-profit biotechnology company, for DNA synthesis services. This sole-source award supports the Vaccine Research Center's efforts to develop vaccine and passive immunotherapy candidates, including monoclonal antibodies, for biodefense-related pathogens such as Ebola and Lassa...
This federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, is for $20,000.00 in custom gene synthesis and expression services provided by Genscript USA Inc., a for-profit biotechnology company located in Piscataway, New Jersey. The contract has a firm fixed price and an ultimate completion date of July 31, 2024. While the original solicitation is not provided, the award likely...